These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 6134140)

  • 1. Diabetic neuropathy--where are we now?
    Lancet; 1983 Jun; 1(8338):1366-7. PubMed ID: 6134140
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldose reductase inhibition for diabetic neuropathy.
    Lancet; 1983 Oct; 2(8356):969. PubMed ID: 6138528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE; Larsen AB; Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetic neuropathy--pathogenesis and precipitating factors].
    Wasada T
    Nihon Rinsho; 1991 Feb; 49 Suppl():159-65. PubMed ID: 1851896
    [No Abstract]   [Full Text] [Related]  

  • 5. ["Diabetic autonomic neuropathy" series. Epidemiology, pathogenesis, basic therapy and prognosis].
    Luft D
    MMW Fortschr Med; 2002 May; 144(20):47-50. PubMed ID: 12119885
    [No Abstract]   [Full Text] [Related]  

  • 6. Fidarestat. Sanwa Kagaku/NC Curex/Sankyo.
    Giannoukakis N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1233-9. PubMed ID: 14649216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aldose reductase inhibitor SNK-860].
    Hibi C
    Nihon Rinsho; 1997 Nov; 55 Suppl():212-5. PubMed ID: 9434469
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of myo-inositol and sorbinil studies.
    Clements RS
    Clin Physiol; 1985; 5 Suppl 5():90-3. PubMed ID: 3938689
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract]   [Full Text] [Related]  

  • 10. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
    Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
    N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes].
    Kuchmerovskaia TM; Donchenko GV; Klimenko AP; Chichkovskaia GV; Pakirbaeva LV; Kozitskiĭ ZIa; Efimov AS
    Ukr Biokhim Zh (1978); 1997; 69(3):77-82. PubMed ID: 9505366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic neurophysiology in diabetes. Basic observations and the effect of treatment.
    Gregersen G
    Clin Physiol; 1985; 5 Suppl 5():79-84. PubMed ID: 3914390
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fidarestat (SNK-860)].
    Hibi C
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():594-600. PubMed ID: 12387056
    [No Abstract]   [Full Text] [Related]  

  • 14. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
    Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
    N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ
    FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
    Malone JI; Lowitt S; Corsico N; Orfalian Z
    Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines in practice: treatment of painful diabetic neuropathy.
    Shenoy AM
    Continuum (Minneap Minn); 2012 Feb; 18(1):192-8. PubMed ID: 22810079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has one diabetic complication been explained?
    Winegrad AI; Simmons DA; Martin DB
    N Engl J Med; 1983 Jan; 308(3):152-4. PubMed ID: 6848907
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug therapy of diabetic neuropathy.
    Brooks PJ; Francisco GE
    Clin Podiatr Med Surg; 1992 Apr; 9(2):257-74. PubMed ID: 1586903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.